Endo, Impax Face Leaner Opana Pay-For-Delay MDL
An Illinois federal judge trimmed claims from a pay-for-delay multidistrict litigation alleging drugmakers Endo and Impax teamed up to keep Opana ER prices high, finding Thursday that indirect purchasers of the...To view the full article, register now.
Already a subscriber? Click here to view full article